Morgan Stanley’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.16M Sell
4,209,670
-90,098
-2% -$153K ﹤0.01% 3761
2025
Q1
$6.79M Buy
4,299,768
+103,899
+2% +$164K ﹤0.01% 3665
2024
Q4
$7.51M Buy
4,195,869
+14,527
+0.3% +$26K ﹤0.01% 3638
2024
Q3
$25.3M Buy
4,181,342
+3,494
+0.1% +$21.2K ﹤0.01% 2551
2024
Q2
$22M Sell
4,177,848
-700
-0% -$3.68K ﹤0.01% 2558
2024
Q1
$35.5M Sell
4,178,548
-4,194,608
-50% -$35.6M ﹤0.01% 2091
2023
Q4
$55.3M Buy
8,373,156
+4,190,473
+100% +$27.7M ﹤0.01% 2330
2023
Q3
$12.9M Buy
4,182,683
+312,603
+8% +$966K ﹤0.01% 2882
2023
Q2
$10.4M Buy
3,870,080
+764,865
+25% +$2.07M ﹤0.01% 3110
2023
Q1
$9.22M Buy
3,105,215
+1,098,738
+55% +$3.26M ﹤0.01% 3222
2022
Q4
$5.06M Sell
2,006,477
-99,542
-5% -$251K ﹤0.01% 3757
2022
Q3
$3.83M Sell
2,106,019
-1,563,661
-43% -$2.85M ﹤0.01% 3911
2022
Q2
$11.6M Buy
3,669,680
+2,119,150
+137% +$6.68M ﹤0.01% 2916
2022
Q1
$9.58M Buy
1,550,530
+1,545,497
+30,707% +$9.55M ﹤0.01% 2952
2021
Q4
$71K Sell
5,033
-108,948
-96% -$1.54M ﹤0.01% 6629
2021
Q3
$912K Sell
113,981
-382,828
-77% -$3.06M ﹤0.01% 5106
2021
Q2
$14.2M Sell
496,809
-76,158
-13% -$2.18M ﹤0.01% 2570
2021
Q1
$16.6M Buy
572,967
+106,253
+23% +$3.09M ﹤0.01% 2109
2020
Q4
$5.57M Buy
466,714
+119,895
+35% +$1.43M ﹤0.01% 3147
2020
Q3
$2.39M Buy
346,819
+220,954
+176% +$1.52M ﹤0.01% 3492
2020
Q2
$780K Buy
+125,865
New +$780K ﹤0.01% 4348
2020
Q1
Sell
-7,589
Closed -$42K 6603
2019
Q4
$42K Buy
+7,589
New +$42K ﹤0.01% 5904
2018
Q1
Sell
-75
Closed 6636
2017
Q4
$0 Sell
75
-500
-87% ﹤0.01% 6588
2017
Q3
$3K Buy
+575
New +$3K ﹤0.01% 6356
2016
Q2
Sell
-183
Closed -$12K 6548
2016
Q1
$12K Hold
183
﹤0.01% 6078
2015
Q4
$15K Sell
183
-442
-71% -$36.2K ﹤0.01% 6120
2015
Q3
$72K Buy
+625
New +$72K ﹤0.01% 5574